Two charts on Midwest cannabis sales
Right on time, the big Midwest states’ cannabis sales have plateaued. Also, medical sales in Michigan continue to plunge as Ohio and Missouri’s medical sales steadily grow.
Right on time, the big Midwest states’ cannabis sales have plateaued. Also, medical sales in Michigan continue to plunge as Ohio and Missouri’s medical sales steadily grow.
Tuesday’s election results will have consequences for cannabis in some states that didn’t have cannabis on the ballot. Here’s a brief rundown on what we see for those states.
Cannabis adult use will expand to two more states, Maryland and Missouri, according to unofficial election results following yesterday’s voting, while ballot measures in Arkansas, South Dakota, and North Dakota, failed.
Michigan’s medical cannabis sales are collapsing. Two years ago the state’s medical cannabis sales totals were almost three times what they are today.
This fall there’s five states with active ballot questions that could legalize adult use cannabis possession on Nov. 8: Arkansas, Maryland, Missouri, North Dakota, and South Dakota. Not all are a sure thing.
Retail adult use cannabis prices in Michigan are half of what they were a year ago and newly reported data from state regulators suggest they have even further to drop this year.
State cannabis operators, many of whom played a direct role in writing the language of the referendum’s proposed constitutional amendment, are confident of passage.
Most Midwest states and New England sales totals generally stayed flat during the summer months.
The DHSS alleges the licensees were operating in unsanitary conditions, including using and applying pesticides without proper training or proper personal protective equipment.
Industry experts like CannaBizIL executive director Pamela Althoff says May’s slight sales decrease isn’t a sign of bad things to come, but likely because workers returning to the office are consuming less cannabis than they would in the privacy of their own homes.